Researchers in the US and Canada have been working to reduce the risk of ototoxic hearing loss, caused by cisplatin.
Cisplatin is a common drug used in cancer treatments; a component drug of certain chemotherapy treatments. Cisplatin is a known ototoxic drug, which can greatly impact the inner ear. It can cause damage to a person’s hearing and balance, as well as leave them with debilitating tinnitus.
The recent research was analysing the use of sodium thiosulfate, and whether it reduced the risk of ototoxic hearing loss.
The study found that people, who were given sodium thiosulfate when undergoing chemotherapy, had a reduced risk of acquiring hearing damage. The use of sodium thiosulfate also had no impact on the effectiveness of the cancer treatment.
